RA Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

RA Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-662	Closed	-$958K	–	48
2015 Q3	$958K	Sell	662 -166	-20%	-$320K	0.14%	43
2015 Q2	$1.82M	Sell	828 -1,402	-63%	-$4.4M	0.18%	39
2015 Q1	$6.64M	Buy	2,230 +261	+13%	+$835K	0.66%	31
2014 Q4	$6.51M	Buy	1,969 +231	+13%	+$818K	0.7%	29
2014 Q3	$6.13M	Buy	+1,738	New	+$6.75M	0.72%	25

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAIG

Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RA Capital Management's FRTX Position: Q4 2015 in Review

RA Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2015, closing a stake of 662 shares — an estimated $958K sold.

RA Capital Management first reported a position in FRTX in Q3 2014 and held it in 5 quarters. The position peaked at $6.64M in Q1 2015. 41 funds tracked by Wall St. Rank hold FRTX as of Q4 2015.

RA Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
RA Capital Management sold 662 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $958K.
RA Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2014 and held it in 5 quarters.
RA Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $6.64M in Q1 2015.
41 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2015.

Based on RA Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.